However, there were no remarkable differences in Notch1 mRNA expression in either peripheral or BALF CD4+ T cells between EGFR mutation and non-EGFR mutation lung adenocarcinoma patients (P=0.852 and 0.403, respectively, Figure 1C,D). The gene discussed is CD4; the disease is lung adenocarcinoma.